21:13 , Jul 30, 2019 |  BC Extra  |  Financial News

June 30 Financial Quick Takes: $40M series B for Hinova; plus TriArm and PredictImmune raise rounds

Hinova Pharmaceuticals raises $40M series B  Hinova Pharmaceuticals Inc (Chengdu, China) completed a $40 million series B round led by Hermed Capital and Shanghai Fosun Pharmaceutical Group Co. Ltd. (Shanghai:600196; HKSE:2196), with participation from Lang...
14:42 , May 20, 2019 |  BC Extra  |  Financial News

May 20 Financial Quick Takes: Schrödinger tops off E round; plus Mabpharm IPO update, DNA Script, ADMA Biologics, Storm

Schrödinger brings E round to $110M  Computational physics company Schrödinger LLC (New York, N.Y.) closed the second tranche of its total $110 million series E round to support development of its technology platform and expand...
23:32 , Apr 30, 2019 |  BC Extra  |  Financial News

April 30 Financial Quick Takes: Mustang, Tot Biopharm, Axcella and more

Mustang raises $27.5M after gene therapy data Mustang Bio Inc. (NASDAQ:MBIO) raised $27.5 million in a follow-on underwritten by Cantor Fitzgerald, Oppenheimer, H.C. Wainwright and Roth Capital. The offering comes on the heels of positive...
14:31 , Apr 26, 2019 |  BC Extra  |  Financial News

Schizophrenia therapy developer Karuna among four biotechs to file for IPOs

Weeks after completing its $80 million series B round, antipsychotic therapy developer Karuna said it has filed confidential documentation with the SEC for a planned IPO. The company was one of four to unveil plans...
18:10 , Apr 23, 2019 |  BioCentury  |  Finance

Accelerating innovations in Cambridge

As the Cambridge, U.K., life sciences start-up environment continues to flourish, Cambridge Innovation Capital’s Michael Anstey believes the city lacked a crucial element to foster start-ups’ growth: a “true U.S.-style accelerator” to provide capital, mentorship...
22:26 , Apr 1, 2019 |  BioCentury  |  Finance

Backing Cambridge's AI boom

After raising £150 million ($196 million) in its latest fund, Cambridge Innovation Capital will be keeping an eye on how artificial intelligence and machine learning technology can be applied to the life science sector. CIC...
19:16 , Apr 1, 2019 |  BC Extra  |  Financial News

Cambridge Innovation raises £150M

Cambridge Innovation raised £150 million ($196 million) to back its portfolio of 25 companies and invest in spinouts from the University of Cambridge and Cambridge area. Cambridge Innovation Capital plc CEO Victor Christou told BioCentury...
21:14 , Mar 28, 2019 |  BC Extra  |  Financial News

Inivata raises £40M series B to support launch of NSCLC liquid biopsy

Inivata completed a £40 million ($52.8 million) series B round to advance the U.S. commercial rollout of its non-small cell lung cancer liquid biopsy following a positive coverage decision from Medicare contractor Palmetto GBA earlier...
21:51 , Feb 22, 2019 |  BioCentury  |  Emerging Company Profile

Gyroscope complements dry AMD

Gyroscope Therapeutics Ltd.’s complement-targeting gene therapy for dry age-related macular degeneration could have an edge over competing therapies that are dosed chronically or target complement downstream of its key immune mediators. On Feb. 19, Gyroscope...
19:51 , Dec 21, 2018 |  BC Week In Review  |  Financial News

Medicxi leads Morphogen-IX’s £18.4M series B

Morphogen-IX Ltd. (Babraham, U.K.) raised £18.4 million ($23.2 million) on Dec. 18 in a series B round led by Medicxi with participation from Cambridge Innovation Capital and Cambridge Enterprise. The company will use the financing...